The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry.
The largest deal of the week based on disclosed price is the acquisition of Vigene Biosciences, Inc. by Charles River Laboratories International, Inc. for $292.5 million in cash upfront. Vigene Biosciences is a gene therapy contract development and manufacturing organization (CDMO) providing viral vector-based gene delivery solutions. The acquisition of Vigene Biosciences will enhance Charles River’s gene therapy capabilities in the high-growth, value-added cell and gene therapy CDMO sector. Vigene is expected to generate annual revenue of $30 to $35 million in 2021 and is expected to grow at least 25% annually over the next five years.
To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets.
Behavioral Health Care | ||
Acquirer | Target | Price |
SMA Healthcare | The Centers in Marion County | N/A |
eHealth | ||
Acquirer | Target | Price |
DarioHealth Corp. | PsyInnovations, Inc. | $25,000,000 |
The Helper Bees | healthAlign | N/A |
The Vistria Group | Medalogix & Muse Healthcare | N/A |
Averhealth | Aspenti | N/A |
BlackRock Long Term Private Capital | Transaction Data Systems | N/A |
Home Health Care & Hospice | ||
Acquirer | Target | Price |
LHC Group, Inc. | 2 Casa de la Luz provider locations | N/A |
HouseWorks, LLC | Intervention Associates | N/A |
Traditions Health, LLC | Area Community Hospice & AmeraCare Family Hospice and Home Health | N/A |
Laboratories, MRI and Dialysis | ||
Acquirer | Target | Price |
Discovery Life Sciences | Targos Molecular Pathology GmbH, Germany | N/A |
Gamma Biosciences | Mirus Bio | N/A |
Long-Term Care | ||
Acquirer | Target | Price |
Chicago Pacific Founders | The Shores at Clear Lake | N/A |
Not disclosed | The Homestead at Lakewood | $8,300,000 |
Managed Care | ||
Acquirer | Target | Price |
Zing Health Enterprises | Lasso Healthcare Insurance Co. | N/A |
Medical Devices | ||
Acquirer | Target | Price |
Shalby Limited | Assets from Consensus Orthopedics | $11,450,000 |
Medline Industries, Inc. | Hudson RCI | $286,000,000 |
Pharmaceuticals | ||
Acquirer | Target | Price |
Advent International | Latin American operations of Perrigo Company | N/A |
Physician Medical Groups | ||
Acquirer | Target | Price |
Texas Children’s Pediatrics | Pediatric practice of Dr. Elsa G. Brieno, MD | N/A |
OMERS Private Equity | Gastro Health, LLC | N/A |
EyeSouth Partners | Retina Care Specialist | N/A |
Beacon Dental Health | 2 downtown Boston dentist practices | N/A |
Podiatry Growth Partners | Foot and Ankle Specialists of Central Ohio | N/A |
Forefront Dermatology | Village Dermatology | N/A |
Rehabilitation | ||
Acquirer | Target | Price |
Concentra Group Holdings, LLC | Occupational health business | N/A |
Other Services | ||
Acquirer | Target | Price |
symplr | HealthcareSource HR Inc. | N/A |
Guardian Pharmacy Services | Hutcheson Homecare Pharmacy | N/A |
Hartford HealthCare | Hunter’s Ambulance Service Inc. | N/A |
Ro Company | Modern Fertility | $225,000,000 |
Charles River Laboratories International, Inc. | Vigene Biosciences, Inc. | $292,500,000 |